Lipid Metabolism Practice Questions

Q: Gangliosides consist of which of the following components?

Sialic acid. **Explanation:** **Gangliosides** are a subclass of **sphingolipids**, specifically categorized as acidic glycosphingolipids. The defining feature of a ganglioside is the presence of one or more residues of **N-acetylneuraminic acid (NANA)**, commonly known as **Sialic acid**. 1. **Why Sialic Acid is Correct:** The basic structure of a ganglioside consists of a **Ceramide** backbone (Sphingosine + Fatty acid) attached to an oligosaccharide chain. What distinguishes gangliosides from neutral glycosphingolipids (like cerebrosides) is the attachment of sialic acid to this sugar chain, which imparts a negative charge to the molecule at physiological pH. 2. **Why Other Options are Incorrect:** * **Glycerol:** Gangliosides are sphingolipids, not phospholipids. They use **sphingosine** as the alcohol backbone instead of glycerol. * **Phosphate:** Gangliosides are non-phosphorylated lipids. Phosphate is a characteristic component of phospholipids (like Lecithin) and Sphingomyelins, but it is absent in glycosphingolipids. * **Nitrogenous base:** While sphingosine contains nitrogen, the term "nitrogenous base" in biochemistry typically refers to purines/pyrimidines (DNA/RNA) or specific bases like choline/ethanolamine found in phospholipids. It is not a defining component of gangliosides. **High-Yield Clinical Pearls for NEET-PG:** * **GM1 Ganglioside:** Acts as the intestinal mucosal receptor for the **Cholera toxin**. * **Tay-Sachs Disease:** Caused by a deficiency of **Hexosaminidase A**, leading to the accumulation of **GM2 ganglioside**. Key findings: Cherry-red spot on macula, no hepatosplenomegaly. * **Guillain-Barré Syndrome (GBS):** Often involves the formation of antibodies against gangliosides (e.g., anti-GM1 antibodies). * **Location:** Gangliosides are most abundant in the **gray matter** of the brain.

Q: A patient presents with a history of recurring attacks of pancreatitis, eruptive xanthomas, and markedly increased plasma triglyceride levels (2,000 mg/dL). Which of the following deficiencies is most likely present?

Lipoprotein Lipase. **Explanation:** The clinical presentation of **recurrent pancreatitis**, **eruptive xanthomas**, and severe hypertriglyceridemia (often >1,000 mg/dL) is characteristic of **Type I Hyperlipoproteinemia** (Familial Chylomicronemia Syndrome). 1. **Why Lipoprotein Lipase (LPL) is correct:** LPL is the key enzyme responsible for hydrolyzing triglycerides in chylomicrons and VLDL into free fatty acids. A deficiency in LPL (or its cofactor, Apo C-II) leads to a massive accumulation of chylomicrons in the plasma. These large particles obstruct pancreatic capillaries, causing ischemia and **pancreatitis**. Eruptive xanthomas (small yellow papules) occur due to lipid uptake by macrophages in the skin. 2. **Why other options are incorrect:** * **LDL Receptors:** Deficiency leads to **Type IIa Hypercholesterolemia**. It presents with high LDL and cholesterol, causing xanthelasmas and tendon xanthomas, but not severe hypertriglyceridemia or pancreatitis. * **HMG-CoA Reductase:** This is the rate-limiting enzyme for cholesterol synthesis. It is the target of statins; its deficiency is not a recognized cause of hyperlipidemia. * **ABCA1 Receptor:** Deficiency causes **Tangier Disease**, characterized by extremely low HDL levels and orange tonsils, not high triglycerides. **NEET-PG High-Yield Pearls:** * **Appearance of Plasma:** In LPL deficiency, if plasma is left standing, a **creamy layer** forms on top (chylomicrons). * **Apo C-II:** Acts as an obligate co-factor for LPL; its deficiency mimics LPL deficiency. * **Treatment:** Primarily a **very low-fat diet** (medium-chain triglycerides are preferred as they bypass chylomicron formation). * **Type IV vs. Type I:** Both involve high triglycerides, but Type IV (VLDL excess) rarely presents with the extreme levels (>2,000 mg/dL) seen in Type I.

Q: Chemically, what characterises oestrogens?

Absence of methyl group at C-10. **Explanation:** The chemical structure of estrogens (such as estradiol, estrone, and estriol) is unique among steroid hormones due to the specific modifications of the steroid nucleus. **1. Why Option C is Correct:** Estrogens are **C-18 steroids**, meaning they contain 18 carbon atoms. During the biosynthesis of estrogens from androgens (like testosterone, which is a C-19 steroid), the enzyme **Aromatase** catalyzes the aromatization of the A-ring. This process involves the **loss of the methyl group at the C-10 position** (the angular methyl group). The absence of this C-10 methyl group allows the A-ring to become phenolic (aromatic), which is the hallmark of estrogenic compounds. **2. Analysis of Incorrect Options:** * **Option A:** Estrogens typically possess a hydroxyl (-OH) or ketone (=O) group at **C-17** (e.g., 17β-estradiol). Oxygen is present at this position, not absent. * **Option B:** The **A-ring** is aromatic in estrogens, not the D-ring. The D-ring remains a saturated five-membered ring. * **Option C:** A 21-carbon skeleton (C-21) characterizes **Progestogens** (e.g., progesterone) and **Corticosteroids** (e.g., cortisol, aldosterone), not estrogens. **High-Yield Clinical Pearls for NEET-PG:** * **Precursor:** Cholesterol (C-27) → Pregnenolone (C-21) → Progesterone (C-21) → Testosterone (C-19) → Estradiol (C-18). * **Rate-limiting step in Steroidogenesis:** Conversion of Cholesterol to Pregnenolone by the enzyme **Desmolase** (CYP11A1) in the mitochondria. * **Aromatase Inhibitors:** Drugs like Anastrozole and Letrozole inhibit the conversion of C-19 androgens to C-18 estrogens, used clinically in ER-positive breast cancer. * **Potency:** 17β-estradiol is the most potent naturally occurring estrogen in premenopausal women.

Q: Which apoprotein is primarily present in LDL?

ApoB-100. **Explanation:** Low-Density Lipoprotein (LDL) is the primary carrier of cholesterol in the blood. It is derived from the metabolism of VLDL (Very Low-Density Lipoprotein) and IDL (Intermediate-Density Lipoprotein). **Why ApoB-100 is correct:** ApoB-100 is the structural apoprotein for VLDL, IDL, and LDL. As VLDL is depleted of triglycerides by lipoprotein lipase, it eventually becomes LDL. During this transition, other apoproteins (like ApoC and ApoE) are lost, leaving **ApoB-100** as the sole and defining apoprotein of LDL. It serves as the ligand for the **LDL receptor**, facilitating cholesterol uptake into peripheral tissues. **Analysis of Incorrect Options:** * **ApoB-48:** This is the truncated version of ApoB synthesized in the intestine. It is the characteristic marker for **Chylomicrons** and their remnants. * **ApoC-I & ApoC-III:** These are "exchangeable" apoproteins found primarily on VLDL and HDL. ApoC-III is notable for inhibiting lipoprotein lipase and hepatic lipase, but neither is the primary structural protein of LDL. **High-Yield Clinical Pearls for NEET-PG:** * **ApoB-100 vs. ApoB-48:** Both are products of the same gene. ApoB-48 is produced via **RNA editing** (C to U conversion creating a stop codon) specifically in the intestine. * **Friedewald Equation:** LDL Cholesterol = Total Cholesterol – [HDL + (Triglycerides/5)]. (Note: Not valid if TG >400 mg/dL). * **Type IIa Hyperlipoproteinemia:** Characterized by a deficiency in LDL receptors, leading to elevated LDL and ApoB-100 levels.

Q: What is the most essential fatty acid?

Linoleic acid. **Explanation:** Essential fatty acids (EFAs) are those that the human body cannot synthesize de novo because humans lack the enzymes (**$\Delta^{12}$ and $\Delta^{15}$ desaturases**) required to create double bonds beyond the $\Delta^9$ position. **Why Linoleic Acid is the Correct Answer:** **Linoleic acid (18:2; $\omega$-6)** is considered the "most essential" because it serves as the primary precursor for the synthesis of other $\omega$-6 fatty acids, including Arachidonic acid. While both Linoleic and $\alpha$-Linolenic acid are essential, Linoleic acid is often prioritized in medical literature as the fundamental EFA because its deficiency leads to clinical symptoms more rapidly and it cannot be synthesized from any other precursor. **Analysis of Incorrect Options:** * **B. Linolenic acid (18:3; $\omega$-3):** This is also an essential fatty acid. However, in the hierarchy of "most essential," Linoleic acid is the primary dietary requirement from which others are derived. * **C. Arachidonic acid (20:4; $\omega$-6):** This is a **semi-essential** fatty acid. It can be synthesized in the body from Linoleic acid. It only becomes essential if there is a dietary deficiency of Linoleic acid. * **D. Palmitic acid (16:0):** This is a saturated fatty acid and is the first fatty acid produced by the **Fatty Acid Synthase (FAS)** complex in the body. It is non-essential. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Deficiency:** EFA deficiency presents as **Phrynoderma** (follicular hyperkeratosis/toad skin), hair loss, and poor wound healing. * **Precursor Role:** Arachidonic acid is the vital precursor for **Prostaglandins, Leukotrienes, and Thromboxanes** (Eicosanoids). * **Ratio:** The ideal dietary ratio of $\omega$-6 to $\omega$-3 is approximately 4:1 to 10:1.

Q: Which of the following is a scavenger of cholesterol from tissues and prevents atherosclerosis?

HDL. ### Explanation **Correct Option: D (HDL)** High-Density Lipoprotein (HDL) is known as the **"Good Cholesterol"** because of its role in **Reverse Cholesterol Transport**. It acts as a scavenger by picking up excess cholesterol from peripheral tissues and vascular walls and transporting it back to the liver for excretion in bile. This process is mediated by the enzyme **LCAT (Lecithin-Cholesterol Acyltransferase)**, which esterifies free cholesterol. By removing cholesterol from the arterial endothelium, HDL prevents the formation of foam cells and inhibits the progression of atherosclerosis. **Incorrect Options:** * **A (VLDL):** Produced by the liver, its primary role is to transport endogenous triglycerides to peripheral tissues. High levels are associated with increased cardiovascular risk, not protection. * **B (LDL):** Known as **"Bad Cholesterol,"** LDL transports cholesterol *from* the liver *to* the peripheral tissues. High levels lead to cholesterol deposition in arterial walls, leading to atherosclerosis. * **C (Chylomicrons):** These are responsible for transporting exogenous (dietary) lipids from the intestines to the liver and peripheral tissues. They are primarily composed of triglycerides. **NEET-PG High-Yield Pearls:** * **Apo A-I:** The major apoprotein associated with HDL; it activates LCAT. * **CETP (Cholesteryl Ester Transfer Protein):** Facilitates the exchange of cholesteryl esters from HDL for triglycerides from VLDL/LDL. * **Tangier Disease:** A rare genetic disorder characterized by a deficiency in the **ABCA1 transporter**, leading to extremely low HDL levels and orange-colored tonsils. * **Protective Level:** An HDL level >60 mg/dL is considered a "negative" risk factor for coronary heart disease.

Q: A 7-month-old child presented with neuro-developmental delay, loss of motor skills, increased startle reaction to noise, feeding difficulties, and failure to thrive. On examination, macrocephaly was noted along with myoclonus and spasticity. There was no evidence of corneal clouding or angiokeratomas. CT scan revealed no hepatosplenomegaly and no cardiac involvement. Fundoscopy revealed specific findings (details omitted for brevity in this example). Which enzyme deficiency is responsible for the above symptoms?

Hexosaminidase A. **Explanation:** The clinical presentation describes a classic case of **Tay-Sachs Disease** (GM2 Gangliosidosis). The key diagnostic triad includes progressive neurodegeneration (loss of motor skills), an exaggerated **startle response** (hyperacusis), and a **cherry-red spot** on the macula (implied fundoscopy finding). The presence of **macrocephaly** (due to reactive gliosis) and the specific **absence of hepatosplenomegaly** are pathognomonic features that differentiate it from other lipid storage disorders. 1. **Hexosaminidase A (Correct):** Deficiency of this enzyme leads to the accumulation of GM2 ganglioside in the gray matter of the brain. This causes the characteristic neuro-regression, macrocephaly, and seizures seen in this infant. 2. **Sphingomyelinase (Incorrect):** Deficiency causes **Niemann-Pick Disease (Type A)**. While it presents with a cherry-red spot and neurodegeneration, it is characterized by **prominent hepatosplenomegaly**, which was absent in this patient. 3. **Alpha-galactosidase A (Incorrect):** Deficiency causes **Fabry Disease**. This presents later in life with angiokeratomas, peripheral neuropathy (burning pain), and renal/cardiac involvement, rather than early-onset neuro-regression. 4. **Beta-galactosidase A (Incorrect):** Deficiency causes **GM1 Gangliosidosis**. This presents with a cherry-red spot and neurodegeneration but typically includes **hepatosplenomegaly** and skeletal abnormalities (dysostosis multiplex). **NEET-PG High-Yield Pearls:** * **Tay-Sachs vs. Niemann-Pick:** Both have cherry-red spots, but Tay-Sachs has **No** organomegaly (No "Pick"ing of the liver/spleen). * **Pathology:** "Onion-skin" lysosomes are seen on electron microscopy in Tay-Sachs. * **Genetics:** Autosomal Recessive; common in Ashkenazi Jews. * **Macrocephaly:** In a child with neuro-regression, think Tay-Sachs, Alexander disease, or Canavan disease.

Q: What is the most important predictor of coronary artery disease?

HDL. **Explanation:** The correct answer is **HDL (High-Density Lipoprotein)**. In clinical practice and biochemistry, the level of HDL is considered the most significant independent predictor of Coronary Artery Disease (CAD). **1. Why HDL is the correct answer:** HDL is known as "Good Cholesterol" because it facilitates **Reverse Cholesterol Transport**. It picks up excess cholesterol from peripheral tissues and vascular endothelium and transports it back to the liver for excretion in bile. High levels of HDL are **cardioprotective** because they prevent the formation of foam cells and atherosclerotic plaques. Conversely, low HDL levels are the strongest lipid predictor of increased cardiovascular risk. **2. Why the other options are incorrect:** * **VLDL (Very Low-Density Lipoprotein):** Primarily transports endogenous triglycerides. While elevated VLDL contributes to metabolic syndrome, it is not as strong a predictor as HDL or LDL. * **LDL (Low-Density Lipoprotein):** Known as "Bad Cholesterol," it transports cholesterol to peripheral tissues. While high LDL is a major risk factor and the primary target for statin therapy, statistically, low HDL is often a more sensitive predictor of future cardiac events. * **Chylomicron:** These transport dietary (exogenous) triglycerides. They are not directly atherogenic; their primary clinical significance relates to pancreatitis when levels are extremely high. **Clinical Pearls for NEET-PG:** * **Apo A-I** is the major apoprotein associated with HDL (anti-atherogenic). * **Apo B-100** is the major apoprotein associated with VLDL and LDL (atherogenic). * **Friedewald Formula:** LDL = Total Cholesterol – (HDL + TG/5). (Note: This is invalid if TG >400 mg/dL). * **The Best Ratio:** The Total Cholesterol/HDL ratio is often used in risk scoring; a higher ratio indicates a higher risk of CAD.

Question 1

Gangliosides consist of which of the following components?

Accepted Answer

Sialic acid

Answer

Nitrogenous base

Answer

Glycerol

Answer

Phosphate

Question 2

A patient presents with a history of recurring attacks of pancreatitis, eruptive xanthomas, and markedly increased plasma triglyceride levels (2,000 mg/dL). Which of the following deficiencies is most likely present?

Accepted Answer

Lipoprotein Lipase

Answer

LDL receptors

Answer

HMG-CoA reductase

Answer

ABCA1 receptor

Question 3

Chemically, what characterises oestrogens?

Accepted Answer

Absence of methyl group at C-10

Answer

Absence of O2 at D-17

Answer

Aromatic character at D-ring

Answer

A 21-carbon steroid skeleton

Question 4

Which apoprotein is primarily present in LDL?

Accepted Answer

ApoB-100

Answer

ApoB-48

Answer

ApoC-I

Answer

ApoC-III

Question 5

What is the most essential fatty acid?

Accepted Answer

Linoleic acid

Answer

Linolenic acid

Answer

Arachidonic acid

Answer

Palmitic acid

Question 6

A young man participates in a nutritional research study. After ingesting a very fatty meal, serum samples are taken for research studies at 1 hour and 3 hours. The studies measure the average diameter of chylomicrons, showing an average diameter of 500 nm at 1 hour, which drops to an average diameter of 150 nm at 3 hours. Where is the enzyme responsible for this change primarily located?

Accepted Answer

Endothelial cells

Answer

Adipocytes

Answer

Enterocytes

Answer

Hepatocytes

Question 7

Which of the following is a scavenger of cholesterol from tissues and prevents atherosclerosis?

Accepted Answer

HDL

Answer

VLDL

Answer

LDL

Answer

Chylomicrons

Question 8

A 7-month-old child presented with neuro-developmental delay, loss of motor skills, increased startle reaction to noise, feeding difficulties, and failure to thrive. On examination, macrocephaly was noted along with myoclonus and spasticity. There was no evidence of corneal clouding or angiokeratomas. CT scan revealed no hepatosplenomegaly and no cardiac involvement. Fundoscopy revealed specific findings (details omitted for brevity in this example). Which enzyme deficiency is responsible for the above symptoms?

Accepted Answer

Hexosaminidase A

Answer

Sphingomyelinase

Answer

Alpha galactosidase A

Answer

Beta galactosidase A

Question 9

Respiratory distress syndrome in premature infants is due to inadequate secretion of which one of the following lipids?

Accepted Answer

Dipalmitoyl phosphatidycholine

Answer

Sphingomyelin

Answer

Cholesterol

Answer

Phosphatidylinositol

Question 10

What is the most important predictor of coronary artery disease?

Accepted Answer

HDL

Answer

VLDL

Answer

LDL

Answer

Chylomicron

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?